Antibiotics that target the 50S ribosome subunit: resistance and other considerations
29 min
Dr. Joyce Sutcliffe NanoBio Corporation, USA
1 TalkBiography
Joyce Sutcliffe is Vice President of Research at NanoBio Corporation a biopharmaceutical company focused on developing and commercializing novel products for the prevention and treatment of infectious diseases. Dr. Sutcliffe has 26 years of experience in the discovery and design of new antibiotics. She was previously Vice President of Biology... read moreand Chief Research Scientist at Rib-X Pharmaceuticals.
